# FDA QMSR & 21 CFR Part 820: ISO 13485 Crosswalk

Last reviewed: October 15, 2026

The FDA Quality Management System Regulation (QMSR) is the new quality management framework (QMS framework) for medical device and IVD manufacturers. QMSR replaced the Quality System Regulation (QSR) under 21 CFR Part 820 and took effect February 2, 2026.

Regulatory Overview

## FDA QMSR is now in effect

The [US Food and Drug Administration](https://www.pureglobal.com/glossary/us-fda) [Quality Management System Regulation (QMSR)](https://www.fda.gov/medical-devices/postmarket-requirements-devices/quality-management-system-regulation-qmsr) became effective on February 2, 2026. It amended the device current good manufacturing practice requirements in 21 CFR Part 820 and incorporated ISO 13485:2016 by reference, together with ISO 9000:2015 Clause 3 for terms and definitions. The former Quality System Regulation language should no longer be described as the current framework.

QMSR harmonizes much of FDA's system with the international medical device QMS standard, but it is not satisfied merely by holding an ISO 13485 certificate. Manufacturers remain responsible for the FDA-specific provisions in Part 820 and other applicable requirements, including complaint handling, Medical Device Reporting, corrections and removals, UDI, and records. FDA can inspect for compliance regardless of whether a certification body has issued a certificate.

## What manufacturers should verify

A practical QMSR assessment should map the organization's procedures and records to the incorporated standard and FDA additions. Priority areas include:

-   risk-based quality planning across the product lifecycle;
-   design and development controls for applicable devices, including software validation;
-   supplier qualification and outsourced-process controls;
-   production, process validation, cleanliness, packaging, and labeling controls;
-   complaint investigation and escalation into MDR, corrections, removals, and CAPA;
-   management review, internal audits, quality records, and inspection readiness; and
-   controls for combination products and other product-specific requirements.

The assessment should be scoped to the legal manufacturer and each site or contractor performing regulated activities. Gaps need owners, evidence, and completion dates rather than a policy-only cross-reference.

## FDA inspections under QMSR

FDA stopped using the Quality System Inspection Technique (QSIT) on February 2, 2026. Device inspections now use the process described in Compliance Program 7382.850. Records that previously received special limits under the former regulation, including management review, quality-audit, and supplier-audit reports, may be reviewed under QMSR. Inspection preparation should therefore include record availability, staff readiness, and evidence that the quality system operates in practice.

## DHF, DMR and DHR under QMSR

The familiar Design History File (DHF), Device Master Record (DMR) and Device History Record (DHR) labels come from the former QSR. FDA's [QMSR final rule, response to Comment 31](https://www.fda.gov/media/177022/download) explains that their elements are largely covered by ISO 13485 documentation requirements, although the separate record-type terms were not retained. Removing a label does not remove the underlying evidence duty.

| Historical record | Current documentation area | Practical handoff |
| --- | --- | --- |
| DHF: design and development history | Clause 7.3.10 design and development file | Retain or reference the records demonstrating applicable design and development compliance |
| DMR: approved specifications and procedures | Clause 4.2.3 medical device file | Connect current product and manufacturing specifications to controlled documents |
| DHR: production history for a device or batch | Clause 7.5.1 device or batch record | Retain production, acceptance and traceability evidence for the released output |

Treat this as an evidence crosswalk, not an instruction to rename three folders and declare compliance. Review content, references, approvals and access against the incorporated standard and FDA additions. Connect [biocompatibility evaluations](https://www.pureglobal.com/markets/united-states/fda-biocompatibility-iso-10993-evaluation-guide) and other verification evidence to the design file, released specification and subsequent change assessments.

## Maintaining compliance

QMSR work is not a one-time conversion project. New products, suppliers, sites, software releases, complaints, regulatory changes, and acquisitions can alter the compliance state. Manufacturers should incorporate QMSR impact checks into design changes, supplier changes, CAPA, management review, and internal-audit programs, and keep the FDA establishment, listing, submission, and post-market obligations aligned with the same controlled quality records.

## QMSR and ISO 13485: a practical crosswalk

This planning map identifies evidence to inspect; it does not reproduce the licensed ISO standard or replace a clause-by-clause applicability assessment.

| FDA provision or obligation | ISO 13485 area to map | Practical evidence |
| --- | --- | --- |
| 21 CFR 820.10: quality-management system | Applicable clauses 4–8 | Controlled scope, processes, risk-based controls and records showing implementation |
| 820.10: design/development for covered devices | Clause 7.3 | Design inputs/outputs, review, verification, validation, transfer and change records |
| 820.10: UDI and other applicable FDA obligations | Identification, traceability and regulatory processes | UDI assignment controls and assessment of Parts 803, 806, 821 and 830 where applicable |
| 820.35: additional record controls | Records, complaints and servicing | Required device identification, complaint investigations and servicing information |
| 820.45: labeling and packaging controls | Production and product preservation | Release checks, labeling inspection, mix-up prevention and traceable acceptance evidence |

FDA incorporates ISO 13485:2016; it does not replace every FDA-specific obligation with certification. Historical QSR references such as 820.30 or 820.100 may help trace old procedures, but should not be presented as the current QMSR section structure. Map the actual current provision and incorporated clause, then verify the operating records.

Connect complaint handling to [Medical Device Reporting](https://www.pureglobal.com/markets/united-states/fda-medical-device-reporting-mdr-consulting) and corrections/removals assessments. Link the final marketed device to [registration/listing](https://www.pureglobal.com/markets/united-states/us-fda-medical-device-establishment-registration-and-device-listing) and its authorized configuration. For an inspection finding, the [Form 483 response guide](https://www.pureglobal.com/markets/united-states/fda-483-and-warning-letter-response-and-consulting) explains how to turn individual corrections into documented systemic remediation.

Connect [standards evidence](https://www.pureglobal.com/markets/united-states/fda-recognized-consensus-standards-and-doc-guide) and [controlled labeling](https://www.pureglobal.com/markets/united-states/fda-21-cfr-part-801-medical-device-labeling-and-iso-15223-symbols) to the released device configuration.

For the detailed requirements mapping, use our [Part 820 to ISO 13485 crosswalk](https://www.pureglobal.com/blog-posts/fda-21-cfr-part-820-to-iso-13485-qmsr-crosswalk-guide).

How We Can Help

## Strengthen FDA QMSR compliance with Pure Global

Plan your device registration, local representation and ongoing compliance with Pure Global.

[Contact us](https://www.pureglobal.com/contact)[Pricing](https://www.pureglobal.com/services/pricing?country=US)

![Pure Global market entry support team](https://www.pureglobal.com/assets/owned/75037ea614--67ab304f89cb5422fdc63bc7__67ab304f89cb5422fdc63d5e_feature_5.webp)

## Frequently asked questions

### Who must comply with the FDA’s new QMSR regulations?

QMSR applies to manufacturers of finished medical devices, including domestic and foreign legal manufacturers and other firms performing covered manufacturing functions such as specification development, contract manufacturing, or remanufacturing. Importers have separate FDA duties and are subject to QMSR provisions only to the extent their activities fall within its scope.

### Is obtaining ISO 13485 certification mandatory to comply with the QMSR?

No. The FDA does not require manufacturers to hold ISO 13485 certification, nor will it accept ISO 13485 certificates in place of FDA inspections or compliance responsibilities. Manufacturers must ensure their quality systems meet the specific requirements of the QMSR and are prepared for FDA audits and inspections regardless of their ISO certification status.

### Will the FDA still accept MDSAP certificates under QMSR?

FDA continues to participate in MDSAP and may use recognized MDSAP audit reports within that program. An MDSAP certificate does not replace compliance with QMSR, FDA registration or listing, required reports, or FDA's authority to inspect. Manufacturers should maintain both the audit evidence and the underlying compliant records.

### Did QMSR eliminate DHF, DMR and DHR documentation?

QMSR did not retain those separate historical record-type terms. FDA explains that the underlying elements are largely required through ISO 13485 records, including the design and development file, medical device file and device or batch production record. Assess the content and traceability rather than simply renaming folders.

## Single Process,  
Multiple Markets

When you partner with Pure Global, a single registration process opens doors to multiple countries. Our global subsidiaries make this streamlined path possible.

[

Argentina



](https://www.pureglobal.com/markets/argentina)

[

Australia



](https://www.pureglobal.com/markets/australia)

[

Bangladesh



](https://www.pureglobal.com/markets/bangladesh)

[

Brazil



](https://www.pureglobal.com/markets/brazil)

[

Canada



](https://www.pureglobal.com/markets/canada)

[

China



](https://www.pureglobal.com/markets/china)

[

Colombia



](https://www.pureglobal.com/markets/colombia)

[

Costa Rica



](https://www.pureglobal.com/markets/costa-rica)

[

Egypt



](https://www.pureglobal.com/markets/egypt)

[

European Union



](https://www.pureglobal.com/markets/european-union)

[

Hong Kong



](https://www.pureglobal.com/markets/hong-kong)

[

India



](https://www.pureglobal.com/markets/india)

[

Indonesia



](https://www.pureglobal.com/markets/indonesia)

[

Israel



](https://www.pureglobal.com/markets/israel)

[

Japan



](https://www.pureglobal.com/markets/japan)

[

Macau



](https://www.pureglobal.com/markets/macau)

[

Malaysia



](https://www.pureglobal.com/markets/malaysia)

[

Mexico



](https://www.pureglobal.com/markets/mexico)

[

New Zealand



](https://www.pureglobal.com/markets/new-zealand)

[

Pakistan



](https://www.pureglobal.com/markets/pakistan)

[

Peru



](https://www.pureglobal.com/markets/peru)

[

Philippines



](https://www.pureglobal.com/markets/philippines)

[

Saudi Arabia



](https://www.pureglobal.com/markets/saudi-arabia)

[

Singapore



](https://www.pureglobal.com/markets/singapore)

[

South Korea



](https://www.pureglobal.com/markets/south-korea)

[

Switzerland



](https://www.pureglobal.com/markets/switzerland)

[

Taiwan



](https://www.pureglobal.com/markets/taiwan)

[

Thailand



](https://www.pureglobal.com/markets/thailand)

[

UAE



](https://www.pureglobal.com/markets/uae)

[

United Kingdom



](https://www.pureglobal.com/markets/united-kingdom)

[

United States



](https://www.pureglobal.com/markets/united-states)

[

Vietnam



](https://www.pureglobal.com/markets/vietnam)

[Canonical page](https://www.pureglobal.com/markets/united-states/us-fda-qmsr-consulting-for-medical-devices)
